Arundati Rao, MBBS
Assistant Professor of Medicine (Nephrology)DownloadHi-Res Photo
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Associate Program Director - Nephrology Fellowship, Internal Medicine
Contact Info
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Associate Program Director - Nephrology Fellowship, Internal Medicine
Contact Info
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Associate Program Director - Nephrology Fellowship, Internal Medicine
Contact Info
About
Titles
Assistant Professor of Medicine (Nephrology)
Associate Program Director - Nephrology Fellowship, Internal Medicine
Appointments
Nephrology
Assistant ProfessorPrimary
Other Departments & Organizations
- Internal Medicine
- Nephrology
- Yale Medicine
Education & Training
- Chief Resident
- University of Connecticut (2020)
- Residency
- University of Connecticut (2019)
- MBBS
- Sri Ramachandra Medical College (2014)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Arundati Rao's published research.
Madhav Menon, MBBS, MD
Publications
2023
Allograft tissue under the microscope: only the beginning
Virmani S, Rao A, Menon M. Allograft tissue under the microscope: only the beginning. Current Opinion In Organ Transplantation 2023, 28: 126-132. PMID: 36787238, PMCID: PMC10214011, DOI: 10.1097/mot.0000000000001052.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAllograft tissueArtificial intelligenceBanff schemaMachine learningDigital pathologyKidney allograft biopsiesApplication of AINovel molecular diagnosticsAllograft healthAllograft histologyAllograft biopsiesPathologic diagnosisImmunological activationTissue injuryHistopathological analysisClinical careTissue pathologyML algorithmsClinical useOrdinal outputsNovel modalityVivo microscopyPathologyBiopsyTissue
2022
Update on Renal Sympathetic Denervation for the Treatment of Hypertension
Rao A, Krishnan N. Update on Renal Sympathetic Denervation for the Treatment of Hypertension. Current Cardiology Reports 2022, 24: 1261-1271. PMID: 35895182, DOI: 10.1007/s11886-022-01753-x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRenal sympathetic denervationTreatment of hypertensionRenal sympathetic nervesPathophysiology of hypertensionSympathetic denervationSympathetic nervesBlood pressureSafety of RSDRenal sympathetic nerve fibersAmbulatory blood pressure measurementsAntihypertensive drug useSham-controlled trialAdvanced kidney diseaseSympathetic nerve fibersLong-term efficacyPurpose of ReviewHypertensionBlood pressure measurementsExcellent safety profileModest treatment effectsLong-term safetyAntihypertensive medicationsAldosterone antagonistsCause mortalityNeurogenic controlResistant hypertensionDonor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms
Jethwani P, Rao A, Bow L, Menon MC. Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms. Frontiers In Immunology 2022, 13: 822353. PMID: 35432337, PMCID: PMC9012490, DOI: 10.3389/fimmu.2022.822353.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAllograft outcomesImportant recent dataRenal allograft outcomeAcute allograft rejectionKidney allograft outcomesDonor-recipient mismatchRecipient's immune systemNatural history studiesNon-HLA lociMajority of casesOrgan allocation processPolymorphic HLA genesAcute rejectionAllograft longevityAllograft lossMaintenance immunosuppressionTransplant outcomesAllograft rejectionImmune mechanismsPatient deathRecipient pairsDonor organsHLA variantsImmune systemOvert evidence
2020
Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
Madgula A, Covello B, Singh M, Rao A, Lee J. Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease. Cureus 2020, 12: e7215. PMID: 32274273, PMCID: PMC7141794, DOI: 10.7759/cureus.7215.Peer-Reviewed Original ResearchCitationsConceptsInterstitial lung diseaseLung diseaseTreatment of interstitial lung diseaseAdvent of immunotherapyAcquired immunodeficiency syndromeTyrosine kinase inhibitorsGrowth factor receptorSmall-sized studiesShortness of breathFibroblast growth factor receptorImmunodeficiency syndromeClinical presentationDormant infectionTalaromycosisFactor receptorFungal infectionsKinase inhibitorsRespiratory symptomsTreat several conditionsEndemic regionsNintedanibPatientsInfectionDiseaseImmunotherapyLife-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors
Rao A, Reddy A, Dinunno C, Elali I. Life-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors. Journal Of Oncology Pharmacy Practice 2020, 26: 1533-1537. PMID: 32054410, DOI: 10.1177/1078155220904141.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsAnaplastic lymphoma kinase inhibitorsTriglyceride levelsAcute pancreatitisKinase inhibitorsMetastatic non-small cell lung cancerNon-small cell lung cancerHypertriglyceridemia-induced acute pancreatitisAnaplastic lymphoma kinase (ALK) rearrangementAnaplastic lymphoma kinase (ALK) mutationsAggressive multidisciplinary managementHypertriglyceridemia-induced pancreatitisPatient's triglyceride levelStage IIIA adenocarcinomaCommon adverse effectsTraditional risk factorsCell lung cancerRight hilar massStandard of careTyrosine kinase inhibitorsEpigastric painConcurrent chemoradiationIntravenous hydrationRespiratory failureRight hilumElevated triglyceridesSuccessful treatment of Hashimoto encephalopathy with therapeutic plasma exchange
bin Attique H, Rao A, Haider L, Trivedi R. Successful treatment of Hashimoto encephalopathy with therapeutic plasma exchange. Therapeutic Apheresis And Dialysis 2020, 24: 599-601. PMID: 31863616, DOI: 10.1111/1744-9987.13466.Peer-Reviewed Original ResearchCitationsAltmetric
Clinical Care
Overview
Clinical Specialties
Nephrology
Fact Sheets
Diagnosing Kidney Disease
Learn More on Yale MedicineLiving Donor Organ Transplantation
Learn More on Yale MedicineKidney Transplant
Learn More on Yale MedicineLiver Transplant
Learn More on Yale Medicine
Board Certifications
Nephrology
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2022
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.